Historical Stock Chart
2 Months : From Jul 2019 to Sep 2019
MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that it has submitted its Evidence of Readiness package to Health Canada and completed construction on Phase 1 of “WARMAN”, a retrofitted indoor cultivation facility located in Winnipeg, Manitoba and the largest in the Company’s portfolio.
“Reaching this Health Canada milestone at our flagship Winnipeg facility is a significant achievement for our company,” noted Eric Gattoni, SVP, Operations of MJardin Group. “We look forward to cultivation at this facility as well as releasing our plans for Phase 2 of the project.” “WARMAN” is MJardin’s fourth Canadian cannabis cultivation facility to submit an Evidence of Readiness package to Health Canada. The facility joins the Company’s portfolio which consists of two facilities in Ontario and one in Nova Scotia. The Company expects to receive its cultivation license for the Warman facility in the fourth quarter of 2019.
About MJardin GroupMJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com
The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
This news release contains forward-looking information based on current expectations. Statements about, among other things, future developments and the business and operations of MJardin, our production capacity, our production results, trading of MJardin’s shares on the OTCQX Best Market, the closing of the Transaction, the receipt of any pending regulatory approvals or licenses, the growth of our global footprint and our intentions to leverage our scale for continued organic growth and to pursue strategic investments are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such factors include, but are not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or invest in. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that the proposed acquisition will occur and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. MJardin assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
INVESTOR CONTACT:Ali MahdaviCapital Markets & Investor Relations416-962-3300Ali.mahdavi@MJardin.com
Adrian T. Montgomery Chairman/Interim Chief Executive Officer 416-309-2077Adrian.Montgomery@Mjardin.com